Related Experiment Video
Updated: Jun 23, 2026
03:50
Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
Constipation, haemorrhoids, and heartburn in pregnancy
1Instituto Nacional de Endocrinologia, Zapata y D, Vedado, Ciudad Habana, Cuba.
BMJ Clinical Evidence
|May 20, 2009
Summary
This systematic review evaluates interventions for common pregnancy-related gastrointestinal issues like constipation, heartburn, and hemorrhoids. It synthesizes evidence on treatments to help expectant mothers find relief.
Area of Science:
- Obstetrics and Gynecology
- Gastroenterology
- Evidence-Based Medicine
Background:
- Constipation, heartburn, and hemorrhoids are frequent gastrointestinal complaints during pregnancy.
- Constipation affects 11-38% of pregnant women, while heartburn incidence ranges from 17-45%.
- Symptomatic hemorrhoids are more prevalent in pregnant women compared to non-pregnant individuals.
Purpose of the Study:
- To systematically review interventions for preventing or treating constipation in pregnancy.
- To systematically review interventions for preventing or treating hemorrhoids in pregnancy.
- To systematically review interventions for preventing or treating heartburn in pregnancy.
Main Methods:
- Conducted a systematic literature review up to July 2007, searching Medline, Embase, and The Cochrane Library.
- Included systematic reviews, randomized controlled trials (RCTs), and observational studies.
- Incorporated safety alerts from regulatory agencies like the FDA and MHRA.
Main Results:
- Identified five systematic reviews, RCTs, or observational studies meeting inclusion criteria.
- Performed a GRADE evaluation to assess the quality of evidence for various interventions.
- Synthesized data on the effectiveness and safety of numerous treatments.
Conclusions:
- The review presents information on interventions including dietary modifications (fiber, fluids, meal size), laxatives (bulk-forming, osmotic, stimulant), antacids, acid-suppressing drugs, topical agents, and lifestyle adjustments.
- Effectiveness and safety data were compiled for treatments addressing pregnancy-related gastrointestinal discomfort.
- Provides a comprehensive overview to guide clinical decisions for managing common pregnancy ailments.
Related Concept Videos
01:25Assessment of the Rectum and Anus
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
01:30Other Disorders of Digestive System
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:25Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
01:29Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...